Phathom Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Phathom Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Phathom Pharmaceuticals Inc
Rating: 1.18108325
Author: Trendlyne DVM scores

about

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

11.11 0.14 (1.28%)

39.32% Fall from 52W High

217.4K

XNAS Volume

XNAS 17 Jul, 2026 12:31 PM (EDT)

Not Eligible

Expensive Valuation

10.8 / 100

Technically Neutral

36.4 / 100

1Yr Price target upside is 113%

10 analysts

Phathom Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Phathom Pharma Inc Live Stock Price Today, Share Analysis and Chart

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

39.32% Fall from 52W High

SWOT Analysis

Phathom Pharma Inc Live Price Chart

Phathom Pharma Inc Live Price Chart